Zachary Shurtleff
1.8K posts
Zachary Shurtleff
@ZachShurtleff
Chief Marketing Officer @strivepharmacy Dad of four Student of life, God, and business Work hard, play hard, and take lots of pictures
Arizona Katılım Aralık 2012
804 Takip Edilen336 Takipçiler
Thanks bro! It’s a topic I’m passionate about. Just very excited about the role compounding pharmacies play in the personalized medicine revolution—and that it, contrary to what people think, purposefully exists as an adjacent system with different regulations to enable that to happen.
Power to the patients and providers!! ✊
English
People keep saying there’s “no evidence” for the peptides voted on at PCAC.
The real-world data, the patent problem, and why compounding is a complementary system (not a rogue challenge to the FDA) are all in this piece.
This is bigger than just a vote. x.com/i/article/2081…
English
@rand_longevity What are the other options than being divided?
English
@ZachShurtleff @Puppieslover Nope, the post is solid. Tigers' orange coat pops to us trichromats but reads as muted green/brown to dichromatic prey like deer and boars, blending into the greenery. The image shows exactly that simulation. Evolution at work.
English
Tigers look orange to humans because we are trichromats, but they appear green to deer and wild boars because they are dichromats.
English
The most important company in AI is an American open source company.
No federal permission slip required.
English
@katiehobbs All of your posts are just a highlight reel. We want more real conversations on real issues, and your perspective on real problems and opportunities in our state.
More transparency needed
English
Stopped by New York Pizza Department in Tucson for a quick bite and even learned how to toss a pizza in the process!
Small businesses like Mark’s keep our economy running, and making sure they have all the support they need to thrive in Arizona will always be one of my biggest priorities.
English
A really strong indicator about the growing interest in peptides.
…But also a really strong indicator that most people don’t actually know what peptides are.
Time to band together and bridge that gap with factual education and proper compounding!
Hims House@himshouse
🚨 BREAKING: "WHAT ARE PEPTIDES" HITS NEW ALL-TIME HIGH ON GOOGLE TRENDS $HIMS $LLY $NVO
English
Check out this article I just dropped, Nick! Although I start by talking about peptides specifically (and them moving to compounding pharmacies), my latter points support what you’re saying and I go into how this adjacent pharma sphere intentionally exists to give providers the freedom to step outside of the trad pharma paradigm and make their own clinical judgements rather than just pick meds off the shelf. Compounding plays a critical, big-picture role in what you’re saying.
Would love if you gave it a read!
Zachary Shurtleff@ZachShurtleff
People keep saying there’s “no evidence” for the peptides voted on at PCAC. The real-world data, the patent problem, and why compounding is a complementary system (not a rogue challenge to the FDA) are all in this piece. This is bigger than just a vote. x.com/i/article/2081…
English
AI has made one thing perfectly clear:
Most doctors are so far behind the health curve it is sickening.
And they are also an incredibly defensive, stubborn, righteous group.
They talk down to people who now finally have a source of truth beyond the pharma machine.
English
You bring up some very fair points, Jen. It looks like you are ultimately referring to the gray market though (considering this picture) where this is all lacking. A compliant compounding pharmacy will have this information readily available at their request.
A passive reporting system also doesn’t fully show all adverse events, but it does tend to capture the critical ones that a patient feels important to report to their provider or to the pharmacy.
Again, things that will be captured when patients get them from a compounding pharmacy, not from the grey market.
That’s a really important distinction because they are two very different sources, and why the vote supported making them available through proper channels.
There wasn’t a single pro-peptide or compounding pharmacy individual at PCAC that was against the need and value for adverse event reporting, and patients and providers are always encouraged to report those.
English
Do we think this vendor’s clients will be able to contact the manufacturer with an AE?
I realize that there are people in this marketplace trying to be as on the “up-and-up” as possible, but I don’t know that I’d try to argue that there’s a strong traceable supply chain for AE reporting.
English
@elonmusk He thinks you’re awesome. And open source AI models
English
A low birth rate due to extended periods of prosperity and low perceived external danger is the primary reason that Rome and most other powerful civilizations collapsed.
Rome had a very high birth rate when under extreme pressure from Carthage and a low birth rate a few generations after Carthage, their last serious threat, was finally destroyed.
Camus@newstart_2024
Rome fell because the Romans stopped making Romans. Elon Musk pointed to the same pattern that appears whenever a civilization gets comfortable: birth rates drop. Julius Caesar noticed it around 50 BC and explored incentives for a third child. Augustus went further with the Lex Julia and Lex Papia Poppaea, creating the ius trium liberorum, privileges, tax relief, and inheritance advantages for those with three or more children, plus penalties for the childless. The laws failed to reverse the trend. Will and Ariel Durant’s reading of history shows the cycle repeating: higher births under stress, decline once external threats ease and prosperity rises. Few exceptions. A society that stays below replacement long enough disappears. Basic arithmetic.
English
I’m excited about it. It gets us together with “our communities” more often. Now you’re spending time with your Elders Quorum or youth group every Sunday instead of only up to 2x per month.
The “by the time everyone settles down” is a cultural thing that will have to change though. It will become critical to get started quicker, and share fewer but more potent topics.
As someone who loves teaching, that’s a fundamental of effective teaching anyway. Heavily focusing on 2 topics is much better than 10 shallow topics shoved into twice the time. The former allows deeper understanding.
it will be an adjustment, but I personally believe the shift of (more touch points with “your people”) + (more poignant topics with shorter lessons) is going to be a huge win.
English
@ManOnThePen Thanks brother! Just trying to aggregate the understanding (and the argument) into one place! 🙏🏼
English
Zachary Shurtleff@ZachShurtleff
People keep saying there’s “no evidence” for the peptides voted on at PCAC. The real-world data, the patent problem, and why compounding is a complementary system (not a rogue challenge to the FDA) are all in this piece. This is bigger than just a vote. x.com/i/article/2081…
English
@DrJesseMorse @RegenRandy Just published this article to consolidate all these critical points x.com/zachshurtleff/…
Zachary Shurtleff@ZachShurtleff
People keep saying there’s “no evidence” for the peptides voted on at PCAC. The real-world data, the patent problem, and why compounding is a complementary system (not a rogue challenge to the FDA) are all in this piece. This is bigger than just a vote. x.com/i/article/2081…
English
The rate-limiting factor for most physicians/surgeons/FDA will always be studies. Even then they will find some way to pick them apart.
This is the biggest barrier. You need $50-100M to run a legitimate sized double blind placebo controlled trial.
No one is funding that for BPC or any other peptide because there’s no patent or ROI.
It will have to be retrospective at best or small studies, with less than 200 patients
The volume will never be enough to impressed a classically trained doctor who does everything by the book
They’re a ‘horse with blinders on’
They have lost the ability to think outside the box
English
Was talking peptides with one of my oldest friends, an orthopedic surgeon. He of course asked for RCTs. Convo below.
I particularly liked the “you’re not a scientist you’re a make people better” part.
English
@juliaoftoronto @nytopinion And here’s my article
Zachary Shurtleff@ZachShurtleff
People keep saying there’s “no evidence” for the peptides voted on at PCAC. The real-world data, the patent problem, and why compounding is a complementary system (not a rogue challenge to the FDA) are all in this piece. This is bigger than just a vote. x.com/i/article/2081…
English
Americans want to inject unproven chemicals. They may soon get their way.
An FDA advisory meeting voted to make it easier to access six experimental #peptides. But the meeting was never just about peptides.
I wrote about why for @nytopinion
nytimes.com/2026/07/25/opi…
English
People keep saying there’s “no evidence” for the peptides PCAC voted on last week.
This claim is out of touch to what the vote really means and the bigger picture.
The real-world data, the patent problem, and why compounding is a complementary system (not a rogue challenge to the FDA) are all in this piece.
Zachary Shurtleff@ZachShurtleff
People keep saying there’s “no evidence” for the peptides voted on at PCAC. The real-world data, the patent problem, and why compounding is a complementary system (not a rogue challenge to the FDA) are all in this piece. This is bigger than just a vote. x.com/i/article/2081…
English